Title:
Mechanistic Interrogation of Phthalimide Neovascular Factor 1 using Network Analysis Tools

Thumbnail Image
Author(s)
Wieghaus, Kristen A.
Gianchandani, Erwin P.
Brown, Milton L.
Papin, Jason A.
Botchwey, Edward A.
Authors
Advisor(s)
Advisor(s)
Editor(s)
Associated Organization(s)
Series
Supplementary to
Abstract
Neovascularization is essential for the survival and successful integration of most engineering tissues after implantation in vivo. The objective of this study was to elucidate possible mechanisms of phthalimide neovascular factor 1 (PNF1), a new synthetic small molecule proposed for therapeutic induction of angiogenesis. Complementary deoxyribonucleic acid microarray analysis was used to identify 568 transcripts in human microvascular endothelial cells (HMVECs) that were significantly regulated after 24-h stimulation with 30 lM of PNF1, previously known as SC-3–149. Network analysis tools were used to identify genetic networks of the global biological processes involved in PNF1 stimulation and to describe known molecular and cellular functions that the drug regulated most highly. Examination of the most significantly perturbed networks identified gene products associated with transforming growth factor-beta (TGF-b), which has many known effects on angiogenesis, and related signal transduction pathways. These include molecules integral to the thrombospondin, plasminogen, fibroblast growth factor, epidermal growth factor, ephrin, Rho, and Ras signaling pathways that are essential to endothelial function. Moreover, real-time reversetranscriptase polymerase chain reaction (RT-PCR) of select genes showed significant increases in TGFb- associated receptors endoglin and beta glycan. These experiments provide important insight into the pro-angiogenic mechanism of PNF1, namely, TGF-b-associated signaling pathways, and may ultimately offer new molecular targets for directed drug discovery.
Sponsor
Date Issued
2007-10
Extent
Resource Type
Text
Resource Subtype
Article
Rights Statement
Rights URI